Alliance Pharma PLC

Alliance Pharma PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)58.40
  • Today's Change0.00 / 0.00%
  • Shares traded3.87m
  • 1 Year change-48.41%
  • Beta0.9306
Data delayed at least 20 minutes, as of Mar 22 2023 16:41 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
Equities ScreenerGo to the Equities Screener
  • World

    A diary full of meetings

    Presidents Xi and Putin reunite, MPs grill Johnson over ‘partygate’ and IMF set to approve $2.9bn Sri Lanka rescue package

  • World

    Just another blue Monday

    Mid-January brings supposed depression, but the week ends in celebration

Key statistics

On Wednesday, Alliance Pharma PLC (APH:LSE) closed at 58.40, 71.08% above the 52 week low of 34.14 set on Nov 24, 2022.
52-week range
34.14Nov 24 2022122.00Apr 08 2022
Short selling activity
Provided by S&P Global Market Intelligence
Previous close58.40
Average volume2.32m
Shares outstanding540.00m
Free float463.36m
P/E (TTM)26.21
Market cap315.36m GBP
EPS (TTM)0.0223
Annual div (ADY)1.78
Annual div yield (ADY)3.04%
Div ex-dateDec 22 2022
Div pay-dateJan 19 2023
Next div ex-dateJun 22 2023
Next div pay-dateJul 18 2023
Data delayed at least 20 minutes, as of Mar 22 2023 16:41 BST.
More ▼

Investors Chronicle View

The last IC recommendation on Alliance Pharma PLC shares was Hold at 62.70 on 21 Mar 2023Read the full article
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.